Back to Companies
Context Therapeutics Inc.
CNTXNasdaqCIK: 0001842952
Context Therapeutics Inc. (CNTX) shows 7 recent insider filings from 7 insiders, with no open-market buying or selling. Minai-Azary Jennifer Lynn (Chief Financial Officer) is the most active by dollar volume, and the single largest transaction was $638.0K by Minai-Azary Jennifer Lynn. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$793.5K
Purchases
$0
Sales
$0
Unique Insiders
7
Recent Insider Trades
7 loaded
| Jun 26 | CNTX Context Therapeutics Inc. | Pasternak Andy | Director | Award | $25.9K |
| Jun 26 | CNTX Context Therapeutics Inc. | Smith Karen L. | Director | Award | $25.9K |
| Jun 26 | CNTX Context Therapeutics Inc. | West Linda | Director | Award | $25.9K |
| Jun 26 | CNTX Context Therapeutics Inc. | Stacey Jennifer Evans | Director | Award | $25.9K |
| Jun 26 | CNTX Context Therapeutics Inc. | Kantoff Philip W. | Director | Award | $25.9K |
| Jun 26 | CNTX Context Therapeutics Inc. | Walker Luke Nathaniel | Director | Award | $25.9K |
| Feb 23 | CNTX Context Therapeutics Inc. | Minai-Azary Jennifer Lynn | Chief Financial Officer | Award | $638.0K |
7 filings